25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EQ (Equillium Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Equillium Inc together

I guess you are interested in Equillium Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Equillium Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Equillium Inc’s Price Targets

I'm going to help you getting a better view of Equillium Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Equillium Inc

I send you an email if I find something interesting about Equillium Inc.

1. Quick Overview

1.1. Quick analysis of Equillium Inc (30 sec.)










1.2. What can you expect buying and holding a share of Equillium Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.30
Expected worth in 1 year
$0.00
How sure are you?
23.3%

+ What do you gain per year?

Total Gains per Share
$-0.29
Return On Investment
-91.7%

For what price can you sell your share?

Current Price per Share
$0.32
Expected price per share
$0.27 - $0.3618
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Equillium Inc (5 min.)




Live pricePrice per Share (EOD)
$0.32
Intrinsic Value Per Share
$2.24 - $2.89
Total Value Per Share
$2.54 - $3.18

2.2. Growth of Equillium Inc (5 min.)




Is Equillium Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$10.5m$23.6m-$4.8m-25.9%

How much money is Equillium Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.4m-$3m-$464.5k-13.3%
Net Profit Margin-32.2%-32.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Equillium Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#585 / 881

Most Revenue
#321 / 881

Most Profit
#361 / 881

Most Efficient
#464 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Equillium Inc?

Welcome investor! Equillium Inc's management wants to use your money to grow the business. In return you get a share of Equillium Inc.

First you should know what it really means to hold a share of Equillium Inc. And how you can make/lose money.

Speculation

The Price per Share of Equillium Inc is $0.321. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Equillium Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Equillium Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.30. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Equillium Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.24-75.5%-0.10-30.5%-0.08-26.4%-0.13-39.6%-0.21-66.7%-0.19-58.8%
Usd Book Value Change Per Share-0.24-74.0%-0.07-22.9%-0.06-17.8%-0.10-30.6%-0.04-11.2%0.013.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.24-74.0%-0.07-22.9%-0.06-17.8%-0.10-30.6%-0.04-11.2%0.013.1%
Usd Price Per Share0.39-0.67-1.13-1.10-2.70-2.86-
Price to Earnings Ratio-0.40--262.35--3.52--88.73--55.23--38.41-
Price-to-Total Gains Ratio-1.65-11.47--23.38--4.99--8.30--12.04-
Price to Book Ratio1.32-1.28-1.79-1.58-2.02-2.06-
Price-to-Total Gains Ratio-1.65-11.47--23.38--4.99--8.30--12.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.321
Number of shares3115
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.07-0.04
Usd Total Gains Per Share-0.07-0.04
Gains per Quarter (3115 shares)-229.27-112.36
Gains per Year (3115 shares)-917.08-449.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-917-9270-449-459
20-1834-18440-899-908
30-2751-27610-1348-1357
40-3668-36780-1798-1806
50-4585-45950-2247-2255
60-5502-55120-2697-2704
70-6420-64290-3146-3153
80-7337-73460-3595-3602
90-8254-82630-4045-4051
100-9171-91800-4494-4500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%2.028.00.06.7%2.028.00.06.7%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%7.023.00.023.3%7.023.00.023.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.030.00.0%0.00.030.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%7.023.00.023.3%7.023.00.023.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Equillium Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.237-0.074-69%-0.057-76%-0.098-59%-0.036-85%0.010-2506%
Book Value Per Share--0.2960.523-43%0.663-55%0.698-58%1.189-75%1.067-72%
Current Ratio--2.7022.938-8%1.972+37%2.613+3%6.761-60%9.347-71%
Debt To Asset Ratio--0.3680.357+3%0.543-32%0.464-21%0.359+2%0.464-21%
Debt To Equity Ratio--0.5810.581+0%1.194-51%0.940-38%0.669-13%0.487+19%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--22363681.39036917837.647-39%54008348.475-59%56935792.457-61%133465195.724-83%157650189.134-86%
Eps---0.242-0.098-60%-0.085-65%-0.127-48%-0.214-12%-0.189-22%
Ev To Ebitda Ratio---0.633103.016-101%-4.898+674%32.542-102%16.724-104%10.513-106%
Free Cash Flow Per Share---0.229-0.129-43%-0.159-31%-0.107-53%-0.152-33%-0.136-40%
Free Cash Flow To Equity Per Share---0.226-0.128-44%-0.213-6%-0.134-41%-0.082-64%0.058-493%
Gross Profit Margin--1.0000.981+2%1.006-1%0.996+0%0.998+0%0.998+0%
Intrinsic Value_10Y_max--2.887----------
Intrinsic Value_10Y_min--2.240----------
Intrinsic Value_1Y_max---0.324----------
Intrinsic Value_1Y_min---0.319----------
Intrinsic Value_3Y_max---0.506----------
Intrinsic Value_3Y_min---0.493----------
Intrinsic Value_5Y_max---0.125----------
Intrinsic Value_5Y_min---0.156----------
Market Cap11465895.300-22%14012681.39023955087.647-42%40389598.475-65%39456709.124-64%96630695.724-85%102175763.916-86%
Net Profit Margin----0.3220%-0.3240%-0.2320%-0.1390%-0.0930%
Operating Margin----0.3010%-0.3020%-0.2190%-0.1310%-0.0880%
Operating Ratio---1.036-100%1.354-100%0.992-100%0.595-100%0.397-100%
Pb Ratio1.084-22%1.3251.285+3%1.786-26%1.582-16%2.020-34%2.058-36%
Pe Ratio-0.331+18%-0.405-262.346+64708%-3.522+770%-88.729+21819%-55.234+13545%-38.411+9389%
Price Per Share0.321-22%0.3920.666-41%1.131-65%1.103-64%2.704-85%2.860-86%
Price To Free Cash Flow Ratio-0.351+18%-0.4291.518-128%-1.996+366%-0.460+7%-2.819+558%-3.874+804%
Price To Total Gains Ratio-1.352+18%-1.65211.465-114%-23.380+1315%-4.987+202%-8.297+402%-12.038+629%
Quick Ratio--2.4163.450-30%2.572-6%3.352-28%9.164-74%12.418-81%
Return On Assets---0.517-0.183-65%-0.058-89%-0.124-76%-0.152-71%-0.171-67%
Return On Equity---0.818-0.275-66%-0.128-84%-0.207-75%-0.227-72%-0.188-77%
Total Gains Per Share---0.237-0.074-69%-0.057-76%-0.098-59%-0.036-85%0.010-2506%
Usd Book Value--10578000.00018812250.000-44%23689000.000-55%24970250.000-58%42509250.000-75%38124826.733-72%
Usd Book Value Change Per Share---0.237-0.074-69%-0.057-76%-0.098-59%-0.036-85%0.010-2506%
Usd Book Value Per Share--0.2960.523-43%0.663-55%0.698-58%1.189-75%1.067-72%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--22363681.39036917837.647-39%54008348.475-59%56935792.457-61%133465195.724-83%157650189.134-86%
Usd Eps---0.242-0.098-60%-0.085-65%-0.127-48%-0.214-12%-0.189-22%
Usd Free Cash Flow---8173000.000-4616250.000-44%-5664250.000-31%-3814333.333-53%-5436550.000-33%-4869903.033-40%
Usd Free Cash Flow Per Share---0.229-0.129-43%-0.159-31%-0.107-53%-0.152-33%-0.136-40%
Usd Free Cash Flow To Equity Per Share---0.226-0.128-44%-0.213-6%-0.134-41%-0.082-64%0.058-493%
Usd Market Cap11465895.300-22%14012681.39023955087.647-42%40389598.475-65%39456709.124-64%96630695.724-85%102175763.916-86%
Usd Price Per Share0.321-22%0.3920.666-41%1.131-65%1.103-64%2.704-85%2.860-86%
Usd Profit---8654000.000-3496750.000-60%-3032250.000-65%-4550833.333-47%-8805200.000+2%-7463259.300-14%
Usd Revenue---7601500.000-100%9473500.000-100%7744833.333-100%4646900.000-100%3097933.333-100%
Usd Total Gains Per Share---0.237-0.074-69%-0.057-76%-0.098-59%-0.036-85%0.010-2506%
 EOD+3 -5MRQTTM+4 -31YOY+8 -273Y+8 -275Y+7 -2810Y+6 -29

3.3 Fundamental Score

Let's check the fundamental score of Equillium Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.331
Price to Book Ratio (EOD)Between0-11.084
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.416
Current Ratio (MRQ)Greater than12.702
Debt to Asset Ratio (MRQ)Less than10.368
Debt to Equity Ratio (MRQ)Less than10.581
Return on Equity (MRQ)Greater than0.15-0.818
Return on Assets (MRQ)Greater than0.05-0.517
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Equillium Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.264
Ma 20Greater thanMa 500.341
Ma 50Greater thanMa 1000.375
Ma 100Greater thanMa 2000.528
OpenGreater thanClose0.325
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Equillium Inc

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and in phase 2 clinical trial for the treatment of ulcerative colitis. The company also develops EQ101, first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, which completed Phase 1/2 to treat cutaneous T cell lymphoma. It serves its products to gastroenterology, dermatology, hematology, transplant science, rheumatology, pulmonology, and oncology areas. The company has a collaboration and license agreement with Biocon SA to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Fundamental data was last updated by Penke on 2025-06-19 05:01:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Equillium Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Equillium Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-32.2%+32.2%
TTM-32.2%YOY-32.4%+0.2%
TTM-32.2%5Y-13.9%-18.2%
5Y-13.9%10Y-9.3%-4.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--91.7%+91.7%
TTM-32.2%-139.0%+106.8%
YOY-32.4%-194.4%+162.0%
3Y-23.2%-248.5%+225.3%
5Y-13.9%-343.3%+329.4%
10Y-9.3%-488.9%+479.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Equillium Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • -51.7% Return on Assets means thatΒ Equillium Inc generatedΒ $-0.52 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Equillium Inc:

  • The MRQ is -51.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-51.7%TTM-18.3%-33.4%
TTM-18.3%YOY-5.8%-12.5%
TTM-18.3%5Y-15.2%-3.1%
5Y-15.2%10Y-17.1%+1.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-51.7%-11.6%-40.1%
TTM-18.3%-11.7%-6.6%
YOY-5.8%-11.4%+5.6%
3Y-12.4%-11.9%-0.5%
5Y-15.2%-12.1%-3.1%
10Y-17.1%-13.8%-3.3%
4.3.1.3. Return on Equity

Shows how efficient Equillium Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • -81.8% Return on Equity means Equillium Inc generated $-0.82Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Equillium Inc:

  • The MRQ is -81.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -27.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-81.8%TTM-27.5%-54.3%
TTM-27.5%YOY-12.8%-14.8%
TTM-27.5%5Y-22.7%-4.8%
5Y-22.7%10Y-18.8%-3.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-81.8%-13.5%-68.3%
TTM-27.5%-15.0%-12.5%
YOY-12.8%-14.5%+1.7%
3Y-20.7%-16.9%-3.8%
5Y-22.7%-17.9%-4.8%
10Y-18.8%-19.9%+1.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Equillium Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Equillium Inc is operatingΒ .

  • Measures how much profit Equillium Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Equillium Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-30.1%+30.1%
TTM-30.1%YOY-30.2%+0.1%
TTM-30.1%5Y-13.1%-16.9%
5Y-13.1%10Y-8.8%-4.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM-30.1%-249.7%+219.6%
YOY-30.2%-208.4%+178.2%
3Y-21.9%-221.7%+199.8%
5Y-13.1%-344.1%+331.0%
10Y-8.8%-470.4%+461.6%
4.3.2.2. Operating Ratio

Measures how efficient Equillium Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Equillium Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.036-1.036
TTM1.036YOY1.354-0.319
TTM1.0365Y0.595+0.441
5Y0.59510Y0.397+0.198
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.108-2.108
TTM1.0362.680-1.644
YOY1.3543.080-1.726
3Y0.9923.621-2.629
5Y0.5954.734-4.139
10Y0.3976.546-6.149
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Equillium Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Equillium Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 2.70Β means the company has $2.70 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Equillium Inc:

  • The MRQ is 2.702. The company is able to pay all its short-term debts. +1
  • The TTM is 2.938. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.702TTM2.938-0.236
TTM2.938YOY1.972+0.966
TTM2.9385Y6.761-3.823
5Y6.76110Y9.347-2.586
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7023.659-0.957
TTM2.9383.834-0.896
YOY1.9724.141-2.169
3Y2.6134.661-2.048
5Y6.7615.756+1.005
10Y9.3476.151+3.196
4.4.3.2. Quick Ratio

Measures if Equillium Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 2.42Β means the company can pay off $2.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Equillium Inc:

  • The MRQ is 2.416. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.450. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.416TTM3.450-1.033
TTM3.450YOY2.572+0.878
TTM3.4505Y9.164-5.714
5Y9.16410Y12.418-3.254
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4162.799-0.383
TTM3.4503.143+0.307
YOY2.5723.794-1.222
3Y3.3524.307-0.955
5Y9.1645.707+3.457
10Y12.4186.457+5.961
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Equillium Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Equillium IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Equillium Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.37Β means that Equillium Inc assets areΒ financed with 36.8% credit (debt) and the remaining percentage (100% - 36.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Equillium Inc:

  • The MRQ is 0.368. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.357. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.368TTM0.357+0.011
TTM0.357YOY0.543-0.187
TTM0.3575Y0.359-0.002
5Y0.35910Y0.464-0.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3680.324+0.044
TTM0.3570.347+0.010
YOY0.5430.329+0.214
3Y0.4640.340+0.124
5Y0.3590.349+0.010
10Y0.4640.379+0.085
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Equillium Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 58.1% means that company has $0.58 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Equillium Inc:

  • The MRQ is 0.581. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.581. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.581TTM0.581+0.001
TTM0.581YOY1.194-0.613
TTM0.5815Y0.669-0.088
5Y0.66910Y0.487+0.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5810.379+0.202
TTM0.5810.435+0.146
YOY1.1940.412+0.782
3Y0.9400.446+0.494
5Y0.6690.460+0.209
10Y0.4870.509-0.022
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Equillium Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Equillium Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.40 means the investor is paying $-0.40Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Equillium Inc:

  • The EOD is -0.331. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.405. Based on the earnings, the company is expensive. -2
  • The TTM is -262.346. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.331MRQ-0.405+0.074
MRQ-0.405TTM-262.346+261.941
TTM-262.346YOY-3.522-258.824
TTM-262.3465Y-55.234-207.112
5Y-55.23410Y-38.411-16.823
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.331-2.282+1.951
MRQ-0.405-2.062+1.657
TTM-262.346-2.541-259.805
YOY-3.522-3.722+0.200
3Y-88.729-3.754-84.975
5Y-55.234-6.100-49.134
10Y-38.411-6.653-31.758
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Equillium Inc:

  • The EOD is -0.351. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.429. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1.518. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.351MRQ-0.429+0.078
MRQ-0.429TTM1.518-1.946
TTM1.518YOY-1.996+3.514
TTM1.5185Y-2.819+4.337
5Y-2.81910Y-3.874+1.055
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.351-3.101+2.750
MRQ-0.429-2.689+2.260
TTM1.518-3.594+5.112
YOY-1.996-4.363+2.367
3Y-0.460-5.065+4.605
5Y-2.819-8.478+5.659
10Y-3.874-9.273+5.399
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Equillium Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.32 means the investor is paying $1.32Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Equillium Inc:

  • The EOD is 1.084. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.325. Based on the equity, the company is underpriced. +1
  • The TTM is 1.285. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.084MRQ1.325-0.241
MRQ1.325TTM1.285+0.040
TTM1.285YOY1.786-0.501
TTM1.2855Y2.020-0.735
5Y2.02010Y2.058-0.038
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0841.932-0.848
MRQ1.3251.848-0.523
TTM1.2852.119-0.834
YOY1.7862.469-0.683
3Y1.5822.526-0.944
5Y2.0203.667-1.647
10Y2.0584.351-2.293
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Equillium Inc.

4.8.1. Institutions holding Equillium Inc

Institutions are holding 19.139% of the shares of Equillium Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Decheng Capital LLC12.45070.4894444730800
2025-03-31Takeda Pharmaceutical Co Ltd5.10924.3951182497700
2025-03-31Vanguard Group Inc2.3571084194800
2025-03-31Cota Capital Management, LLC1.574210056227800
2025-03-31Renaissance Technologies Corp0.75450.000226950081003.0987
2025-03-31Geode Capital Management, LLC0.574902053679820.4805
2025-03-31Acadian Asset Management LLC0.30430.00011086911086910
2025-03-31Callan Capital, LLC0.27910.00299968800
2025-03-31State Street Corp0.167205972000
2025-03-31Citadel Advisors Llc0.1558055649556490
2025-03-31DCF Advisers, LLC0.11060.007439492-23455-37.2615
2025-03-31BlackRock Inc0.1035036967-702-1.8636
2025-03-31Northern Trust Corp0.09803501900
2024-12-31Commonwealth Equity Services Inc0.0702500000
2024-12-31UBS Group AG0.0485017309-2042-10.5524
2025-03-31Virtu Financial LLC0.03910.000313954-1735-11.0587
2025-03-31TRITONPOINT WEALTH LLC0.03780.000513500135000
2025-03-31Morgan Stanley - Brokerage Accounts0.0287010238335348.7001
2025-03-31Tower Research Capital LLC0.01910.0001681985614.3552
2024-12-31Wells Fargo & Co0.00280100000
Total 24.2851104.8968674424+163197+1.9%

4.9.2. Funds holding Equillium Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv1.5981057083500
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.69270.000124743000
2025-04-30Fidelity Extended Market Index0.27950.000199839-954-0.9465
2025-04-30Fidelity Total Market Index0.098703524000
2025-05-31iShares Micro-Cap ETF0.08520.00153043500
2025-04-30Fidelity Series Total Market Index0.068702455400
2025-04-30Spartan Extended Market Index Pool F0.05010.0001178979545.6306
2025-04-30Vanguard Instl Ttl Stk Mkt Idx InstlPls0.0501785700
2024-12-31Vanguard Instl Ttl Stck Mkt Idx Tr0.050.00011785700
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.04730.00011689600
2025-03-31NT Ext Equity Mkt Idx Fd - L0.04590.00011638000
2025-03-31Northern Trust Extended Eq Market Idx0.04590.00011638000
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03680.000113152-239-1.7848
2025-04-30Fidelity Nasdaq Composite Index0.026409425-9276-49.6016
2025-04-30Spartan Total Market Index Pool G0.02530903300
2025-04-30Vanguard U.S. Eq Idx Β£ Acc0.01630582600
2025-05-31State St US Extended Mkt Indx NL Cl C0.01150.0001410000
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0110.00013934310.7943
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01090.0002390339030
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.01090.0002390339030
Total 3.26120.00291164876-1678-0.1%

5.3. Insider Transactions

Insiders are holding 35.898% of the shares of Equillium Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-01-23Jason A KeyesSELL100000.65
2024-11-14Jason A KeyesSELL100000.7
2024-10-28Christine ZedelmayerSELL150001.25
2024-10-28Penny TomSELL28351.25
2024-10-25Penny TomSELL6831.25
2024-09-26Jason A KeyesSELL100000.81
2024-09-16Penny TomSELL388060.85
2024-07-16Jason A KeyesSELL100000.87
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Other Current Liabilities  5,6469076,553-1,5045,049-1,9313,118-3,378-260



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets16,729
Total Liabilities6,151
Total Stockholder Equity10,578
 As reported
Total Liabilities 6,151
Total Stockholder Equity+ 10,578
Total Assets = 16,729

Assets

Total Assets16,729
Total Current Assets16,216
Long-term Assets513
Total Current Assets
Cash And Cash Equivalents 14,502
Other Current Assets 1,714
Total Current Assets  (as reported)16,216
Total Current Assets  (calculated)16,216
+/-0
Long-term Assets
Property Plant Equipment 513
Long-term Assets  (as reported)513
Long-term Assets  (calculated)513
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,002
Long-term Liabilities149
Total Stockholder Equity10,578
Total Current Liabilities
Short-term Debt 146
Accounts payable 3,058
Other Current Liabilities -260
Total Current Liabilities  (as reported)6,002
Total Current Liabilities  (calculated)2,944
+/- 3,058
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt149
Long-term Liabilities  (as reported)149
Long-term Liabilities  (calculated)149
+/-0
Total Stockholder Equity
Common Stock3
Retained Earnings -202,461
Accumulated Other Comprehensive Income 731
Other Stockholders Equity 212,305
Total Stockholder Equity (as reported)10,578
Total Stockholder Equity (calculated)10,578
+/-0
Other
Capital Stock3
Cash and Short Term Investments 14,502
Common Stock Shares Outstanding 35,587
Liabilities and Stockholders Equity 16,729
Net Debt -14,207
Net Invested Capital 10,578
Net Working Capital 10,214
Property Plant and Equipment Gross 513
Short Long Term Debt Total 295



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
0
0
7,151
6,728
6,728
6,422
67,163
62,727
57,888
62,995
55,539
49,911
44,259
92,385
85,428
106,838
99,837
92,470
85,405
74,235
62,472
48,631
78,421
71,790
58,764
55,225
50,530
43,597
42,861
34,457
25,604
16,729
16,72925,60434,45742,86143,59750,53055,22558,76471,79078,42148,63162,47274,23585,40592,47099,837106,83885,42892,38544,25949,91155,53962,99557,88862,72767,1636,4226,7286,7287,15100
   > Total Current Assets 
0
0
7,149
6,706
6,706
5,060
67,163
62,629
57,796
62,909
55,539
49,822
44,178
92,160
85,428
106,615
99,566
92,170
83,760
72,085
60,482
46,776
77,230
70,220
57,356
53,911
49,349
42,480
41,887
33,646
24,978
16,216
16,21624,97833,64641,88742,48049,34953,91157,35670,22077,23046,77660,48272,08583,76092,17099,566106,61585,42892,16044,17849,82255,53962,90957,79662,62967,1635,0606,7066,7067,14900
       Cash And Cash Equivalents 
0
0
7,103
6,626
6,626
4,983
28,509
21,394
22,661
27,657
13,219
20,614
24,083
49,249
23,982
50,861
73,525
77,155
50,366
26,244
23,808
25,729
59,107
24,503
25,624
34,382
23,216
11,568
11,057
15,448
18,085
14,502
14,50218,08515,44811,05711,56823,21634,38225,62424,50359,10725,72923,80826,24450,36677,15573,52550,86123,98249,24924,08320,61413,21927,65722,66121,39428,5094,9836,6266,6267,10300
       Short-term Investments 
0
0
0
0
0
0
37,405
40,213
34,283
34,581
39,924
27,061
18,523
41,288
58,181
53,218
24,118
13,539
30,345
42,579
33,754
18,793
11,916
37,489
22,754
11,924
17,650
20,717
22,242
10,429
4,490
0
04,49010,42922,24220,71717,65011,92422,75437,48911,91618,79333,75442,57930,34513,53924,11853,21858,18141,28818,52327,06139,92434,58134,28340,21337,405000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,838
3,424
3,743
3,769
6,286
8,490
6,992
6,196
1,144
0
01,1446,1966,9928,4906,2863,7693,7433,4242,8380000000000000000000000
       Other Current Assets 
0
0
46
0
80
156
1,186
2,044
1,704
1,342
2,288
4,294
3,144
3,246
3,265
5,072
3,846
2,952
3,049
6,524
5,840
4,508
4,465
4,804
5,235
3,836
2,197
1,705
1,596
1,573
1,259
1,714
1,7141,2591,5731,5961,7052,1973,8365,2354,8044,4654,5085,8406,5243,0492,9523,8465,0723,2653,2463,1444,2942,2881,3421,7042,0441,1861568004600
   > Long-term Assets 
0
0
0
0
22
1,361
64
98
92
86
108
89
81
225
254
223
271
300
1,645
2,150
1,990
1,855
1,191
1,570
1,408
1,314
1,181
1,117
974
811
626
513
5136268119741,1171,1811,3141,4081,5701,1911,8551,9902,1501,6453002712232542258189108869298641,361220000
       Property Plant Equipment 
0
0
2
22
22
32
64
83
77
71
93
89
81
225
239
223
254
243
1,645
2,005
1,869
1,742
1,191
1,474
1,321
1,235
1,111
1,055
921
766
626
513
5136267669211,0551,1111,2351,3211,4741,1911,7421,8692,0051,64524325422323922581899371778364322222200
       Intangible Assets 
0
0
0
0
0
0
23
0
0
0
38
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003800023000000
       Other Assets 
0
0
0
0
0
1,329
-64
15
15
15
-108
0
0
0
-254
0
17
57
153
145
121
113
3,369
0
87
79
0
0
0
0
0
0
000000798703,36911312114515357170-254000-108151515-641,32900000
> Total Liabilities 
0
0
9,403
12,322
589
16,800
2,228
3,233
3,825
14,036
13,691
13,565
13,287
14,259
15,574
14,958
15,064
16,668
18,900
21,605
22,205
20,471
46,479
42,521
31,783
31,117
27,957
22,503
20,428
11,280
6,543
6,151
6,1516,54311,28020,42822,50327,95731,11731,78342,52146,47920,47122,20521,60518,90016,66815,06414,95815,57414,25913,28713,56513,69114,0363,8253,2332,22816,80058912,3229,40300
   > Total Current Liabilities 
0
0
569
917
581
2,680
2,028
3,052
3,662
4,274
3,883
3,711
3,387
5,145
7,245
7,417
4,980
7,778
8,915
13,113
15,188
14,930
32,038
32,020
25,218
28,199
27,573
22,208
20,169
11,057
6,356
6,002
6,0026,35611,05720,16922,20827,57328,19925,21832,02032,03814,93015,18813,1138,9157,7784,9807,4177,2455,1453,3873,7113,8834,2743,6623,0522,0282,68058191756900
       Short-term Debt 
0
0
8,059
10,518
10,518
0
0
0
0
0
0
0
0
833
1,666
2,500
10,067
1,250
1,804
3,697
5,154
6,556
6,122
6,522
832
856
880
424
700
274
197
146
1461972747004248808568326,5226,1226,5565,1543,6971,8041,25010,0672,5001,6668330000000010,51810,5188,05900
       Short Long Term Debt 
0
0
8,059
10,518
10,518
0
0
0
0
0
0
0
0
833
1,666
2,500
0
1,250
1,428
2,857
4,286
5,714
5,714
5,714
0
0
0
0
0
0
0
0
000000005,7145,7145,7144,2862,8571,4281,25002,5001,6668330000000010,51810,5188,05900
       Accounts payable 
0
0
244
347
347
1,230
1,119
1,588
1,974
2,675
1,873
1,801
1,761
1,681
2,766
2,324
1,816
2,669
1,225
4,210
5,091
2,469
3,977
5,692
3,026
3,635
4,707
2,778
4,486
3,666
2,676
3,058
3,0582,6763,6664,4862,7784,7073,6353,0265,6923,9772,4695,0914,2101,2252,6691,8162,3242,7661,6811,7611,8011,8732,6751,9741,5881,1191,23034734724400
       Other Current Liabilities 
0
0
141
0
234
1,449
909
1,464
1,688
1,599
2,010
1,910
1,626
2,631
2,813
2,593
3,164
3,859
5,886
5,206
4,943
5,905
7,239
9,102
12,401
12,265
9,460
5,646
6,553
5,049
3,118
-260
-2603,1185,0496,5535,6469,46012,26512,4019,1027,2395,9054,9435,2065,8863,8593,1642,5932,8132,6311,6261,9102,0101,5991,6881,4649091,449234014100
   > Long-term Liabilities 
0
0
0
0
8
14,121
200
181
163
9,762
9,808
9,854
9,900
9,114
8,329
7,541
10,084
8,890
9,985
8,492
7,017
5,541
14,441
10,501
6,565
2,918
384
295
259
223
187
149
1491872232592953842,9186,56510,50114,4415,5417,0178,4929,9858,89010,0847,5418,3299,1149,9009,8549,8089,76216318120014,12180000
       Long term Debt Total 
0
0
0
0
0
10,322
0
0
0
9,616
9,681
9,746
9,810
9,043
8,275
0
0
8,873
8,750
7,370
5,992
0
0
0
0
0
0
0
0
0
0
0
000000000005,9927,3708,7508,873008,2759,0439,8109,7469,6819,61600010,32200000
       Other Liabilities 
0
0
776
887
887
2,524
200
181
163
146
127
108
90
71
54
35
17
17
0
0
0
0
10,378
0
5,956
2,420
0
0
0
0
0
0
0000002,4205,956010,37800001717355471901081271461631812002,52488788777600
       Deferred Long Term Liability 
0
0
0
0
0
1,329
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000001,32900000
> Total Stockholder Equity
0
0
-2,252
-2,252
6,139
-10,379
64,935
59,494
54,063
48,959
41,848
36,346
30,972
78,126
69,854
91,880
84,773
75,802
66,505
52,630
40,267
28,160
31,942
29,269
26,981
24,108
22,573
21,094
22,433
23,177
19,061
10,578
10,57819,06123,17722,43321,09422,57324,10826,98129,26931,94228,16040,26752,63066,50575,80284,77391,88069,85478,12630,97236,34641,84848,95954,06359,49464,935-10,3796,139-2,252-2,25200
   Common Stock
0
0
0
0
0
0
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
33333333333332222221111111000000
   Retained Earnings Total Equity00000000000-161,523-147,394-109,977-99,356-89,074-79,916-70,925-62,007-55,410-48,949-41,112-33,545-27,531-21,462-15,512-10,52000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
5
49
87
80
21
474
97
-30
-297
-255
-209
-66
-138
-454
-149
193
76
305
340
458
140
423
251
-3
781
731
731781-325142314045834030576193-149-454-138-66-209-255-297-3097474218087495000000
   Capital Surplus 
0
0
0
0
0
142
80,441
80,906
81,506
82,423
82,938
84,820
86,284
140,161
141,074
172,049
174,054
175,222
176,618
200,475
201,936
0
0
0
0
0
0
0
0
0
0
0
00000000000201,936200,475176,618175,222174,054172,049141,074140,16186,28484,82082,93882,42381,50680,90680,44114200000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
11,743
142
80,447
80,906
81,506
82,423
82,938
84,820
86,284
140,161
141,074
172,049
174,054
175,222
176,618
200,475
201,936
203,142
204,268
205,306
206,326
207,045
208,170
209,142
210,185
211,190
212,084
212,305
212,305212,084211,190210,185209,142208,170207,045206,326205,306204,268203,142201,936200,475176,618175,222174,054172,049141,074140,16186,28484,82082,93882,42381,50680,90680,44714211,7430000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue41,095
Cost of Revenue-137
Gross Profit40,95840,958
 
Operating Income (+$)
Gross Profit40,958
Operating Expense-49,364
Operating Income-8,269-8,406
 
Operating Expense (+$)
Research Development37,428
Selling General Administrative11,936
Selling And Marketing Expenses0
Operating Expense49,36449,364
 
Net Interest Income (+$)
Interest Income1,381
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,381
 
Pretax Income (+$)
Operating Income-8,269
Net Interest Income1,381
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,706-8,832
EBIT - interestExpense = -7,706
-7,706
-8,067
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-7,706-7,706
Earnings Before Interest and Taxes (EBITDA)-7,569
 
After tax Income (+$)
Income Before Tax-7,706
Tax Provision-361
Net Income From Continuing Ops-8,067-8,067
Net Income-8,067
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses49,364
Total Other Income/Expenses Net563-1,381
 

Technical Analysis of Equillium Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Equillium Inc. The general trend of Equillium Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Equillium Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Equillium Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Equillium Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.3442 < 0.346 < 0.3618.

The bearish price targets are: 0.27.

Know someone who trades $EQ? Share this with them.πŸ‘‡

Equillium Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Equillium Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Equillium Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Equillium Inc. The current macd is -0.01933625.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Equillium Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Equillium Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Equillium Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Equillium Inc Daily Moving Average Convergence/Divergence (MACD) ChartEquillium Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Equillium Inc. The current adx is 9.76037258.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Equillium Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Equillium Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Equillium Inc. The current sar is 0.34.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Equillium Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Equillium Inc. The current rsi is 43.26. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Equillium Inc Daily Relative Strength Index (RSI) ChartEquillium Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Equillium Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Equillium Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Equillium Inc Daily Stochastic Oscillator ChartEquillium Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Equillium Inc. The current cci is -53.8353157.

Equillium Inc Daily Commodity Channel Index (CCI) ChartEquillium Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Equillium Inc. The current cmo is -11.3868865.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Equillium Inc Daily Chande Momentum Oscillator (CMO) ChartEquillium Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Equillium Inc. The current willr is -46.25922023.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Equillium Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Equillium Inc Daily Williams %R ChartEquillium Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Equillium Inc.

Equillium Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Equillium Inc. The current atr is 0.03653759.

Equillium Inc Daily Average True Range (ATR) ChartEquillium Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Equillium Inc. The current obv is 71,908,756.

Equillium Inc Daily On-Balance Volume (OBV) ChartEquillium Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Equillium Inc. The current mfi is 31.43.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Equillium Inc Daily Money Flow Index (MFI) ChartEquillium Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Equillium Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Equillium Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Equillium Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.264
Ma 20Greater thanMa 500.341
Ma 50Greater thanMa 1000.375
Ma 100Greater thanMa 2000.528
OpenGreater thanClose0.325
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Equillium Inc with someone you think should read this too:
  • Are you bullish or bearish on Equillium Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Equillium Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Equillium Inc

I send you an email if I find something interesting about Equillium Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Equillium Inc.

Receive notifications about Equillium Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.